Canada markets open in 8 hours 34 minutes

Cullinan Therapeutics, Inc. (CGEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.14-0.02 (-0.09%)
At close: 04:00PM EDT
23.14 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
18,943
0
-
Operating Expenses
Research Development
126,706
148,156
91,948
57,751
43,211
-
Selling General and Administrative
44,176
42,493
40,189
29,146
17,124
-
Total Operating Expenses
170,882
190,649
132,137
86,897
60,335
-
Operating Income or Loss
-170,882
-190,649
-132,137
-67,954
-60,335
-
Total Other Income/Expenses Net
-352
-201
276,842
-8
-11
-
Income Before Tax
-148,422
-169,223
151,316
-67,485
-59,458
-
Income Tax Expense
-
-14,122
42,121
0
-
-
Income from Continuing Operations
-134,300
-155,101
109,195
-67,485
-59,458
-
Net Income
-132,348
-153,162
111,214
-65,570
-51,799
-
Net Income available to common shareholders
-132,348
-153,162
111,214
-65,570
-51,799
-
Basic EPS
-3.76
-
2.46
-1.52
-1.37
-1.07
Diluted EPS
-3.76
-
2.38
-1.52
-1.37
-1.07
Basic Average Shares
42,287
-
45,164
43,077
41,398
19,361
Diluted Average Shares
42,553
-
46,640
43,077
41,398
19,361